AIZ
61
5
HSIC
42
2
M
40
3
AXP
63
3
UNP
38
5
T
32
2
JWN
72
9
VTR
44
4
HP
44
14
WAT
55
11
SYK
50
4
PEG
53
7
BAX
38
2
EQIX
59
2
ADI
54
4
BIIB
36
8
CRM
65
6
INTU
54
2
CI
35
2
KIM
58
2
AIZ
61
5
HSIC
42
2
M
40
3
AXP
63
3
UNP
38
5
T
32
2
JWN
72
9
VTR
44
4
HP
44
14
WAT
55
11
SYK
50
4
PEG
53
7
BAX
38
2
EQIX
59
2
ADI
54
4
BIIB
36
8
CRM
65
6
INTU
54
2
CI
35
2
KIM
58
2
Financhill
Back

Ligand Pharmaceuticals Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

LGND
Ligand Pharmaceuticals

Last Price:
$116.50
Seasonality Move:
9.17%

7 Day Trial

ALL ACCESS PASS

$ 7

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.

Ligand Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Ligand Pharmaceuticals has on average historically risen by 16.1% based on the past 30 years of stock performance.
  • Ligand Pharmaceuticals has risen higher in 15 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Ligand Pharmaceuticals Stock Undervalued?
    The current Ligand Pharmaceuticals [LGND] share price is $114.58. The Score for LGND is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Ligand Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Ligand Pharmaceuticals has on average historically risen by 16.1% based on the past 30 years of stock performance.

Ligand Pharmaceuticals Stock Rating

Sell
50
Ligand Pharmaceuticals (LGND) is a Sell

Is Ligand Pharmaceuticals overpriced?

  • Ligand Pharmaceuticals has risen higher in 15 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Ligand Pharmaceuticals Stock Price History

Is LGND stock going to rise?

  • The current trend is moderately bearish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ligand.com

52-Week Data

52-Week High:
129.90
52-Week Low:
67.53

Prediction Charts

Market Cap:
2.2B
Price in USD:
114.58
Volume:
528.7K
Beta:
1.44

Technical Analysis

SMA50:
114.96
SMA100:
108.65
SMA200:
95.37
52-Wk Change:
65.27%

Stock Predictions

  • Is Ligand Pharmaceuticals stock public?
    Yes, Ligand Pharmaceuticals is a publicly traded company.
  • What is the Ligand Pharmaceuticals stock quote today?
    The Ligand Pharmaceuticals stock price is 114.58 USD today.
  • How to buy Ligand Pharmaceuticals stock online?
    You can buy Ligand Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 122.61 119.93 123.32 119.50
Dec-4 120.01 120.98 123.00 119.73
Dec-5 120.08 123.51 124.24 120.08
Dec-6 124.11 124.83 127.86 122.89
Dec-9 124.78 116.34 125.50 114.15
Dec-10 116.81 118.60 119.77 114.00
Dec-11 121.18 120.36 122.07 118.48
Dec-12 120.26 113.51 120.94 113.39
Dec-13 113.70 116.91 117.28 113.59
Dec-16 117.30 122.34 124.03 117.30
Dec-17 122.09 120.43 123.20 116.89
Dec-18 121.26 114.35 121.31 113.33
Dec-19 114.57 113.95 119.27 112.49
Dec-20 112.06 114.58 115.47 111.00

Ligand Pharmaceuticals Earnings

Ligand Pharmaceuticals Earnings Report: Per Share Ligand Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ligand Pharmaceuticals Forecast Revenue Growth

Ligand Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Ligand Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.52 per share.

* Ligand Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.